Aggressiveness of Care at the End-of-Life in Cancer Patients and Its Association With Psychosocial Functioning in Bereaved Caregivers

Study Registration https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022837,DRKS00022837. Background Intensified oncological treatment for advanced cancer patients at the end-of-life has been specified as aggressiveness of care (AOC) and increased over the past decades. The aims of this study were to 1) determine the frequency of AOC in Central Europe, and 2) investigate differences in mental health outcomes in bereaved caregivers depending on whether the decedent had experienced AOC or not. Materials and methods We conducted a cross-sectional study in a large tertiary comprehensive cancer care center in Germany. Bereaved caregivers provided information about (a) treatment within the last month of life of the deceased cancer patient and (b) their own mental health status, i.e., decision regret, complicated grief, depression, and anxiety. After multiple imputation of missing data, differences in mental health outcomes between AOC-caregivers and non-AOC-caregivers were analyzed in a multivariate analysis of variances. Results We enrolled 298 bereaved caregivers of deceased cancer patients. AOC occurred in 30.9% of all patients. In their last month of life, 20.0% of all patients started a new chemotherapy regimen, and 13.8% received ICU-treatment. We found differences in mental health outcomes between bereaved AOC- and non-AOC-caregivers. Bereaved AOC caregivers experienced significantly more decision regret compared to non-AOC caregivers (Cohen’s d = 0.49, 95% CI [0.23, 0.76]). Conclusion AOC occurs frequently in European health care and is associated with poorer mental health outcomes in bereaved caregivers. Future cohort studies should substantiate these findings and explore specific trajectories related to AOC. Notwithstanding, shared-decision making at end-of-life should increasingly account for both patients’ and caregivers’ preferences.

[1]  R. Epstein,et al.  The impact of the caregiver-oncologist relationship on caregiver experiences of end-of-life care and bereavement outcomes , 2020, Supportive Care in Cancer.

[2]  V. Chopra,et al.  Interventions to reduce aggressive care at end of life among patients with cancer: a systematic review. , 2019, The Lancet. Oncology.

[3]  C. Chouaid,et al.  Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care , 2019, BMJ Supportive & Palliative Care.

[4]  H. Friederich,et al.  Assessing decision regret in caregivers of deceased German people with cancer—A psychometric validation of the Decision Regret Scale for Caregivers , 2019, Health expectations : an international journal of public participation in health care and health policy.

[5]  S. Meghani,et al.  Associations Among End-of-Life Discussions, Health-Care Utilization, and Costs in Persons With Advanced Cancer: A Systematic Review , 2019, The American journal of hospice & palliative care.

[6]  Yong-Man Kim,et al.  Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution , 2018, BMC Palliative Care.

[7]  Jessica Ogarek,et al.  Site of Death, Place of Care, and Health Care Transitions Among US Medicare Beneficiaries, 2000-2015 , 2018, JAMA.

[8]  P. Maciejewski,et al.  Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer. , 2018, Journal of pain and symptom management.

[9]  P. Maciejewski,et al.  Advanced cancer caregiving as a risk for major depressive episodes and generalized anxiety disorder , 2018, Psycho-oncology.

[10]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[11]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[12]  Ronald C. Chen,et al.  Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years , 2017, Journal of the National Cancer Institute.

[13]  Susan C. Miller,et al.  Association between aggressive care and bereaved families’ evaluation of end‐of‐life care for veterans with non‐small cell lung cancer who died in Veterans Affairs facilities , 2017, Cancer.

[14]  L. Elo,et al.  End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study , 2017, Acta oncologica.

[15]  J. Teno,et al.  Family Perspectives on Aggressive Cancer Care Near the End of Life. , 2016, JAMA oncology.

[16]  SeowHsien,et al.  The CaregiverVoice Survey: A Pilot Study Surveying Bereaved Caregivers To Measure the Caregiver and Patient Experience at End of Life , 2016 .

[17]  C. Tournigand,et al.  End‐of‐life care for hospitalized patients with metastatic melanoma in France: a nationwide, register‐based study , 2016, The British journal of dermatology.

[18]  E. Emanuel,et al.  Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. , 2016, JAMA.

[19]  K. Kahn,et al.  Family Perspectives on Aggressive Cancer Care Near the End of Life. , 2015, JAMA.

[20]  R. Riechelmann,et al.  The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4. , 2015, Clinical colorectal cancer.

[21]  G. Bosshard,et al.  Chemotherapy near the end of life: a retrospective single-centre analysis of patients’ charts , 2014, BMC Palliative Care.

[22]  N. Keating,et al.  Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study , 2014, BMJ : British Medical Journal.

[23]  Michael J. Stern,et al.  The State of Survey Methodology , 2014 .

[24]  F. Burge,et al.  Challenges and strategies in the administration of a population based mortality follow-back survey design , 2013, BMC Palliative Care.

[25]  V. Fuchs How and why US health care differs from that in other OECD countries. , 2013, JAMA.

[26]  E. Hoster,et al.  The role of relatives in decisions concerning life-prolonging treatment in patients with end-stage malignant disorders: informants, advocates or surrogate decision-makers? , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  S. Braga Why do our patients get chemotherapy until the end of life? , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  C. Earle,et al.  The effect on survival of continuing chemotherapy to near death , 2011, BMC palliative care.

[29]  N. Keating,et al.  Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  B. Löwe,et al.  The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. , 2010, General hospital psychiatry.

[31]  Jonathon P Leider,et al.  Expensive cancer drugs: a comparison between the United States and the United Kingdom. , 2009, The Milbank quarterly.

[32]  P. Maciejewski,et al.  Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. , 2008, JAMA.

[33]  C. Earle,et al.  Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Kazuki Sato,et al.  Factors contributing to evaluation of a good death from the bereaved family member's perspective , 2008, Psycho-oncology.

[35]  S. Braga,et al.  The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis , 2007, Psycho-oncology.

[36]  P. Maciejewski,et al.  An empirical examination of the stage theory of grief. , 2007, JAMA.

[37]  Xianggui Qu,et al.  Multivariate Data Analysis , 2007, Technometrics.

[38]  K. Holli,et al.  Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer , 2006, Breast Cancer Research and Treatment.

[39]  C. Earle,et al.  Trends in the aggressiveness of cancer care near the end of life. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Deb Feldman-Stewart,et al.  Validation of a Decision Regret Scale , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[41]  K. Schulz,et al.  An overview of clinical research: the lay of the land , 2002, The Lancet.

[42]  C. McPherson,et al.  After-death interviews with surrogates/bereaved family members: some issues of validity. , 2001, Journal of pain and symptom management.

[43]  H. Pinedo,et al.  Aggressive combination therapy to cure patients with metastatic cancer. , 2000, The Lancet. Oncology.

[44]  P. Simmonds,et al.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis , 2000, BMJ : British Medical Journal.

[45]  J. Hinton,et al.  How reliable are relatives' retrospective reports of terminal illness? Patients and relatives' accounts compared. , 1996, Social science & medicine.

[46]  C. Reynolds,et al.  Inventory of complicated grief: A scale to measure maladaptive symptoms of loss , 1995, Psychiatry Research.

[47]  B. Beutler,et al.  A retrospective cohort study , 2021 .

[48]  Palliative Medicine Bereavement outcomes: a quantitative survey identifying risk factors in family carers bereaved through cancer , 2016 .

[49]  D. Bainbridge,et al.  The CaregiverVoice Survey: A Pilot Study Surveying Bereaved Caregivers To Measure the Caregiver and Patient Experience at End of Life. , 2016, Journal of palliative medicine.

[50]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[51]  M. Haan,et al.  Hard-to-survey populations , 2014 .

[52]  K. Wolter,et al.  Hard-to-Survey Populations: Data collection strategies for the hard to survey , 2014 .

[53]  D. Holmes,et al.  Lay of the Land , 2011 .

[54]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[55]  A. Conversi,et al.  A COMPARATIVE ANALYSIS) , 2008 .

[56]  C. McPherson,et al.  Judging the quality of care at the end of life: can proxies provide reliable information? , 2003, Social science & medicine.

[57]  A. Neugut,et al.  Quality of life at the end of life: trends in patients with metastatic prostate cancer. , 2002, Urology.

[58]  J. Läuter Sample Size Requirements for the T2 Test of MANOVA (Tables for One‐way Classification) , 1978 .